WANBURY
Back to All Ratios
|
WANBURY Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/EBIT(x) | 6.80 | 16.41 | 3.14 | 33.39 | 1.97 |
What is the latest EV/EBIT ratio of WANBURY ?
Year | EV/EBIT |
---|---|
Mar2024 | 6.80 |
Mar2023 | 16.41 |
Mar2022 | 3.14 |
Mar2021 | 33.39 |
Mar2020 | 1.97 |
How is EV/EBIT of WANBURY Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 6.8 | -58.56 | |
Mar2023 | 16.41 | 422.61 | |
Mar2022 | 3.14 | -90.60 | |
Mar2021 | 33.39 | 1,594.92 | |
Mar2020 | 1.97 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹790.0 Cr | -2.1% | -13.2% | 66% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -2.1% |
-13.2% |
66% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses